期刊文献+

双水平无创正压通气应用于慢性阻塞性肺疾病合并呼吸衰竭患者72h疗效观察 被引量:7

The 72 hours' s clinical effect observation on bilevel positive airway pressure ventilation in the patients of chronic obstructive pulmonary disease complicated with respiratory failure
下载PDF
导出
摘要 目的探讨双水平无创正压通气(bilevel positive airway pressure ventilation,BiPAP)对慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)合并呼吸衰竭患者的早期临床疗效。方法根据是否给予BiPAP,将120例入选患者分为治疗组与对照组。分析两组患者的动脉血气及生命体征,观察有无不良反应发生,并比较两组患者的转归。结果①经治疗同时间点酸碱度(power of hydrogen,pH)、动脉血氧分压(arterial partial pressure of oxygen,PaO2)、动脉血二氧化碳分压(partial pressure of arterial carbon dioxide,PaCO2)、动脉血氧饱和度(arterial oxygen saturation,SaO2)、心率(heart rate,HR)、呼吸频率(resparitory rate,RR)治疗组明显优于对照组,且两组间疗效差异均具有统计学意义(P<0.05)。②治疗组有不良反应出现,但都能配合与耐受,对照组均未出现明显不良反应。③治疗组有效率明显高于对照组(P<0.05)。结论 BiPAP治疗COPD合并呼吸衰竭疗效确切、耐受性好,能有效改善预后,是一种行之有效的治疗方法,应予早期应用。 Objective To explore the effect of bilevel positive airway pressure ventilation (BiPAP) on chronic obstructive pulmonary disease (COPD) complicated with respiratory failure. Methods According to whether or not giving Bi- PAP, all of 120 patients selected were divided into treatment group and control group. Arterial blood gas of the two groups, observed the adverse reactions were analyzed and outcomes of the two groups were compared. Results (1)The treatment group's power of hydrogen(pH), arterial partial pressure of oxygen(PaO2), partial pressure of arterial carbon dioxide(PaCO2), arterial oxygen saturation(SaO2), heart rate(HR) and resparitory rate(RR)at the same time after treatment were better than control group, and the differences of the curative effect were significant (P〈0.05). (2)The treat- ment group had adverse reactions to appear, but can cooperate and tolerance, the control group had no obvious ad- verse reaction occurred. (3)The effective rate of treatment group was obviously significantly higher than that of control group (P〈0.05). Conclusion BiPAP is an effective treatment method on COPD complicated with respiratory failure, easy to tolerance, and can effectively improve the prognosis, should be early applicated.
出处 《中国现代医生》 2014年第3期13-16,共4页 China Modern Doctor
基金 河南大学第一附属医院院内科研项目(院行[2012]38号)
关键词 双水平无创正压通气 慢性阻塞性肺疾病 呼吸衰竭 Bilevel positive airway pressure ventilation Chronic obstructive pulmonary disease Respiratory failure
  • 相关文献

参考文献11

  • 1GOLD Executive Committee. Global strategy for the diag- nosis, management, and prevention of chronic obstructive pulmonary desease(updated 2013)[M]. Global Initiative for Chronic Obstructive Lung Disease, Inc, 2013: 65.
  • 2慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中华结核和呼吸杂志,2013,36(4):255-264. 被引量:3864
  • 3中华医学会呼吸病学分会临床呼吸生理及ICU学组.无创正压通气临床应用中的几点建议[J].中华结核和呼吸杂志,2002,25(3):130-134. 被引量:496
  • 4Ward NS, Dushay KM. Clinical concise review: Mechani- cal ventilation of patients with chronic obstructive pul- monary disease[J]. Crit Care Med,2008,36(5): 1614-1619.
  • 5Albertson TE,Louie S,Chan AL. The diagnosis and treat- mentl of elderly patients with acute exacerbation of chronic obstructive pulmonary disease and chronic bron- chitis[J]. J Am Geriatr Soe, 2010,58 (3): 570-579.
  • 6Takada K,Matsumoto S,Hiramatsu T,et al. Predictors of survival inpatients with chronic hypercapnie respiratoryfailure receiving domiciliary NPPV[J]. Nihon Kokyuki Gakkai Zasshi, 2008,46 (8) : 614.
  • 7陈文彬,潘祥林.诊断学[M].第7版.北京:人民卫生出版社.2008:314-315.
  • 8慢性阻塞性肺疾病无创机械通气治疗研究协作组.早期应用无创正压通气治疗慢性阻塞性肺疾病急性加重期患者的多中心随机对照研究[J].中华结核和呼吸杂志,2005,28(10):680-684. 被引量:226
  • 9Nava S,Ambrosino N, Clini E,et al. Noninvasive mechan- ical ventilation in the weaning of patients with respiratory failure due to chronic obstructive pulmonary disease, a randomized,controlled trial[J]. Ann Intern Med, 1998,128 (9):721-728.
  • 10Carvalho AR,Spieth PM,Pelosi P,et al. Pressure sup- port ventilation and biphasic positive airway pressure improve oxygenation by redistribution of pulmonary blood flow[J]. Anesth Analg,2009,109(3):856-865.

二级参考文献40

共引文献4683

同被引文献65

  • 1谢盛,程德云.血浆BNP水平对老年COPD患者肺动脉高压及预后的评估意义[J].四川医学,2012,33(11):1899-1901. 被引量:10
  • 2金超阳.BiPAP无创机械通气联合纳洛酮醒脑静治疗肺性脑病32例[J].中国实用神经疾病杂志,2013,16(18):97-98. 被引量:5
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8235
  • 4Kupry(s)-Lipi(n)ska I,Kuna P.Impact of chronic obstructive pulmonary disease (COPD) on patient's life and his family[J].Pneumonol Alergol Pol,2014,82(2):82-95.
  • 5Minai OA,Chaouat A,Adnot S.Pulmonary hypertension in COPD:epidemiology,significance,and management:pulmonary vascular disease:the global perspective[J].Chest,2010,137 (Supp l):39-51.
  • 6Chaouat A,Naeije R,Weitzenblum E.Pulmonary hypertension in COPD[J].Eur Respir J,2008,32(5):1371-1385.
  • 7Bonnet S,Archer SL.Potassium channel diversity in the pulmonary arteries and pulmonary veins:implications for regulation of the pulmonary vasculature in health and during pulmonary hypertension[J].Pharmacol Ther,2007,115(1):56-69.
  • 8Zakynthinos E,Daniil Z,Papanikolaou J,et al.Pulmonary hypertension in COPD:pathophysiology and therapeutic targets[J].Curr Drug Targets,2011,12(4):501-513.
  • 9Semenza GL.Regulation of oxygen homeostasis by hypoxia-inducible factor 1[J].Physiology (Bethesda),2009,24:97-106.
  • 10Voelkel NF,Mizuno S,Bogaard HJ.The role of hypoxia in pulmonary vascular diseases:a perspective[J].Am J Physiol Lung Cell Mol Physiol,2013,304(7):L457-465.

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部